World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
122
Citations
58461
World Ranking
3456
National Ranking
1900

Overview

Ravi Salgia is affiliated with the City Of Hope National Medical Center in the United States. Their research spans multiple interconnected fields centered primarily around oncology, molecular biology, and pulmonary and respiratory medicine.

The scientist's work heavily focuses on lung cancer treatments, mutations, and diagnostic methodologies, as well as cancer immunotherapy and biomarkers. Their contributions also extend to cancer genomics, radiomics, machine learning in medical imaging, and studies on global cancer incidence and screening.

Frequent coauthors collaborating with Salgia include:

  • Isa Mambetsariev
  • Erminia Massarelli
  • Sharad S. Singhal
  • Prakash Kulkarni
  • Atish Mohanty

Publications featuring Salgia's work are often found in prominent journals such as Cancer Research, Journal of Clinical Medicine, Cancers, Journal of Clinical Oncology, and Journal of Thoracic Oncology. The quantity of publications in these venues indicates sustained research activity in cancer-related areas.

Some notable recent papers include:

  • The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC), 2021, Cell Reports Medicine
  • Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells, 2024, Cancers
  • Immune Checkpoint Inhibitor-Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases, 2021, The Oncologist

Additional influential publications closely related to their field but authored primarily by collaborators include:

  • Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion, 2020, Cancer Cell
  • BindingDB Entry 50022503: A novel small molecule met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-MET tyrosine kinase., 2025, PubMed

The main and subfields of study emphasize a multidisciplinary approach integrating medicine, biochemistry, genetics, and molecular biology with a strong oncology focus. Salgia's research interests increasingly address molecular pathways, therapeutic resistance, and immune mechanisms within cancer pathophysiology.

Best Publications

  • Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

    Eunice L. Kwak;Yung-Jue Bang;D. Ross Camidge;Alice T. Shaw

  • Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer

    Alice T. Shaw;Sai Hong I. Ou;Yung Jue Bang;D. Ross Camidge

  • Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study.

    D. Ross Camidge;Yung Jue Bang;Eunice L. Kwak;A. John Iafrate

  • Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations.

    Jun Gong;Alexander Chehrazi-Raffle;Srikanth Reddi;Ravi Salgia

  • Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis.

    Alice T. Shaw;Beow Y. Yeap;Benjamin J. Solomon;Gregory J. Riely

  • Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.

    A. Singal;M. L. Volk;A. Waljee;R. Salgia

  • c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention

    James G. Christensen;Jon Burrows;Ravi Salgia

  • Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors

    Garrett M. Frampton;Siraj M. Ali;Mark Rosenzweig;Juliann Chmielecki

  • c-Met: Structure, functions and potential for therapeutic inhibition

    Patrick C. Ma;Gautam Maulik;Gautam Maulik;James Christensen;Ravi Salgia;Ravi Salgia

  • The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups

    Michael T. Jaklitsch;Francine L. Jacobson;John H.M. Austin;John K. Field

  • Functional Expression and Mutations of c-Met and Its Therapeutic Inhibition with SU11274 and Small Interfering RNA in Non–Small Cell Lung Cancer

    Patrick C. Ma;Ramasamy Jagadeeswaran;Simha Jagadeesh;Maria S. Tretiakova

  • Activity of XL184 (cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer

    Razelle Kurzrock;Steven I. Sherman;Douglas W. Ball;Arlene A. Forastiere

  • Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition.

    Gautam Maulik;Amol Shrikhande;Takashi Kijima;Patrick C. Ma

  • Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification.

    Sai Hong Ignatius Ou;Eunice L. Kwak;Christina Siwak-Tapp;Joni Dy

  • Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer

    Jalees Rehman;Hannah J. Zhang;Peter T. Toth;Yanmin Zhang

  • c-MET Mutational Analysis in Small Cell Lung Cancer Novel Juxtamembrane Domain Mutations Regulating Cytoskeletal Functions

    Patrick Chi-Chung Ma;Takashi Kijima;Gautam Maulik;Edward A. Fox

  • Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion

    Rui Su;Lei Dong;Yangchan Li;Min Gao

  • Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer

    Daniel V.T. Catenacci;Melissa R. Junttila;Theodore Karrison;Nathan Bahary

  • MET Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib

    Jochen K. Lennerz;Eunice L. Kwak;Allison Ackerman;Michael Michael

  • The role of ephrins and Eph receptors in cancer.

    Hanna Surawska;Patrick C. Ma;Ravi Salgia

Frequent Co-Authors

Martin Sattler
Martin Sattler Harvard University
Everett E. Vokes
Everett E. Vokes University of Chicago
James D. Griffin
James D. Griffin Harvard University
Alice T. Shaw
Alice T. Shaw Harvard University
Hedy L. Kindler
Hedy L. Kindler University of Chicago
Sai-Hong Ignatius Ou
Sai-Hong Ignatius Ou University of California, Irvine
Surinder K. Batra
Surinder K. Batra University of Nebraska Medical Center
Theodore Karrison
Theodore Karrison University of Chicago
Mark J. Ratain
Mark J. Ratain University of Chicago
Mark K. Ferguson
Mark K. Ferguson University of Chicago

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering Medicine in the USA opens pathways beyond traditional medical school. Many students explore specialized online degrees and certifications to launch or boost their healthcare careers. For example, healthcare administration and support roles are in high demand, and getting your medical coding certification cost much less when completed fully online.

Nursing remains a popular career option, thanks to its job stability and diverse roles. Those looking to advance quickly can find the cheapest np school online to become a nurse practitioner remotely. Entry into nursing is also more accessible through the cheapest online nursing programs available across the country.

Ambitious professionals seeking leadership or academic positions may consider an online nursing doctorate. These flexible options make it possible for working students to manage studies and progress in their careers without taking time off.

Best Scientists Citing Ravi Salgia

Trending Scientists